2,454,116 Shares Outstanding If we take the current management ownership of 2,081,924 shares and add it to the total shares owned by previous directors/employers/management (269,625) we get a total of 2,351,549 shares.
The total shares outstanding (2,454,116) minus total shares owned by current and former Lifeloc employees/directors (2,351,549) gives us a grand total of 102,567 shares that can be purchased by outside traders/investors. That is astounding. The true float available for public purchase sits around 100,000 shares. -At a current stock price of $3.00, the entire float could be locked up for around $748,000. I don't know if there is any other publicly traded stock that can say that.
(This company has the Lowest public float of all marijuana/cannabis stocks
+ in the lowest 20 floats of all
US based publicly traded companies) Total assets $8,028,098
CASH, END OF PERIOD $3,383,541
Lifeloc (OTC:LCTC) is a public company established in 1983. We introduced our first breathalyzer to the US Department of Transportation in 1988. We are an American manufacturer of professional-grade, platinum fuel cell based instruments for alcohol detection, measurement and enforcement.
Since our founding, our corporate mission has been to build the most precise, reliable and easiest to use breath alcohol testing devices in the industry. We take pride in offering everything an organization requires to establish an effective alcohol monitoring program including equipment, mouthpieces, factory authorized training and certifications, and a complete line of alcohol testing supplies and calibration equipment. -Today, our highly accurate and reliable fuel cell devices are the preferred choice by professionals in countries around the world. We back everything we sell with exemplary customer service and technical support. -Lifeloc makes the world safer from alcohol and drug abuse by delivering superior products, services and value to our customers.
-Lifeloc is committed to providing products that exceed expectations and industry standards. We accomplish this by faithfully listening to our customers, improving our processes and providing great service -Every Lifeloc breath alcohol tester utilizes the latest platinum fuel cell technology and our proprietary alcohol detection and measurement algorithms to ensure precision and reliability. In addition, we supply the highest quality drug testing supplies creating a one stop shop for all your safety testing needs. “As marijuana legalization spreads across the country and the world, the need to get rapid and reliable testing methods to law enforcement officers will only increase. Providing this technology is consistent with Lifeloc’s corporate mission to make our roads and workplaces safer,” said Dr. Wayne Willkomm, CEO of Lifeloc Technologies. Feasibility of detection has already been demonstrated for very low levels of delta-9-THC (the primary psychoactive agent of marijuana), cocaine, and methamphetamine. Dr. Willkomm commented, “It is an exciting time to be at Lifeloc. We are well positioned for growth and I look forward to building the business through an increasingly effective alcohol and drug detection product pipeline.”
Lifeloc is expanding its product portfolio into “near and remote sensing” opportunities outside of alcohol testing. In September 2014 the company received an award of $250,000 from the Colorado Office of Economic Development and International Trade for the continued development of a THC breathalyzer for detection of the psychoactive compound in Marijuana which causes impairment.
Lifeloc has previously introduced our efforts in THC breath detection, more commonly referred to as a marijuana breathalyzer. We are taking our core competency in designing and building rugged, portable, real-time analytical devices and leveraging that with trace compound detection technology from the U.S. Naval Research Laboratories. This work is being accelerated by a $250,000 grant from the Colorado Office of Economic Development and International Trade to match certain R&D expenditures on this marijuana breathalyzer. Thus far, we have demonstrated the sensitivity to detect extremely small amounts of delta-9-tetrahydrocannabinol (delta-9-THC), the main psychoactive ingredient in marijuana, under perfect conditions in the laboratory. Work continues to develop this capability in a portable device and under real world conditions with interfering components as present in a breath sample.
• The DOA market is ripe for a new technology play to replace traditional blood and urine testing, improve customer service and reduce prices.
• The Alcohol testing market is fragmented with excellent product and segment consolidation opportunities.
• No one company provides a comprehensive alcohol and drug testing solution set to the marketplace.
• The opportunity is to build a $1billion business in 10 years.
Marijuana/cannabis related products offered by Lifeloc.
Drug screening products:
We offer a full line of drugs of abuse (DOA) testing products including saliva tests, collection cups, test cups, dip cards, adulteration strips, bluing tablets and other testing supplies.
Marijuana and the workplace online drug training course
Cannabis impairment goggles
Drug and alcohol policy guidance
Drug and alcohol employee awareness course
SpinDx: Our New Drug Testing Technology:
Solution: A mobile DOA analyzer to identify and quantify drug types from a fluid sample in under 10 minutes.
Approach: Partnering with Sandia National Labs to adapt newly commercialized technology for DOA analysis (including THC). Four issued patents with exclusive license to Lifeloc in selected DOA fields of use. Technology: “lab -on - a -disk” technology, using centrifugally driven microfluidics to manipulate unique reagent beads with the test fluid in small disks.
Detection platform for bodily fluid analysis for a panel of drugs and marijuana breathalyzer.
SpinDx Development Status:
• Lifeloc has exclusive license Drugs of Abuse field of use following a cooperative research and development agreement
• Technology already licensed and commercialized for other fields of use
• Lifeloc has demonstrated detection of ?-9 THC down to 5 ng/ml
• Lifeloc has existing channel to both Law Enforcement and Workplace markets Sandia National Laboratories is operated and managed by National Technology and Engineering Solutions of Sandia, LLC., a wholly owned subsidiary of Honeywell International, Inc. Honeywell is a big boy and has revenue over $36 Billion/year Sandia National Laboratories has an annual budget of $3.6 Billion The inventors of the SpinDx platform are licensing the technology to several companies that are developing its use for point-of-care diagnostics testing, water pathogen testing, and other applications. This is where Lifeloc comes in. They are using the SpinDx platform, in combination with the LX9 base breathalyzer platform to create a device for drug detection. 4 years ago Lifeloc acquired the exclusive rights to develop, manufacture and market Sandia's patented SpinDx™ technology for the detection of drugs of abuse. They received the prototype almost 3 years ago and have been working to commercialize the device. They have detected delta-9-THC (the primary psychoactive component of marijuana) down to concentrations of 5 nanograms per milliliter in their laboratory. Lifloc added staff in early 2020 to help with the development of the SpinDx platform. They are attempting to introduce the marijuana breathalyzer and drug detection device by the end of this year. We believe Lifeloc is the best positioned company in this space. They already have a great existing customer base from their line of alcohol breathalyzers. They know the regulatory compliance and standards conformity government agencies require in a breathalyzer, as well as calibration standards. Their technology using the SpinDx platform allows a whole array of testing for other drugs than just THC, including cocaine and methamphetamines, If they can incorporate the marijuana breathalyzer into their RADAR System, this would set them apart from competitors, and greatly increase the market. It would allow biometric user identification, immediate reporting through a cellular network to a secure portal with gps coordinates and time stamp of each test. The market would expand to not only police doing field sobriety tests, but include Department of Corrections to manage pre-trial, probation or parole clients, DUI and Drug Courts for rehabilitation monitoring, supporting the recovery, treatment, and restoration of clients to be contributing members of society. The units could aid wellness courts in monitoring clients, and help break the cycles of drug and alcohol addicted people, as well as in Family Law where the client would be monitored and provide samples during time spent with court ordered visitation of their children to provide a safe environment. This expands the market greatly, and Lifeloc is the leader here. I also believe that the US government will prefer to purchase equipment made by a US company, as President Biden signed the Executive Order strengthening Buy American, ensuring the future of America is made in America, by American workers. Lifeloc is based in the Us, whereas a main competitor is not. -The cannabis testing market will be worth $1.8 Billion by 2025. That's annual growth of over 13%